Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Inventory Average: 2013-2024

Historic Inventory Average for Ani Pharmaceuticals (ANIP) over the last 12 years, with Dec 2024 value amounting to $124.0 million.

  • Ani Pharmaceuticals' Inventory Average rose 4.13% to $142.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.4 million, marking a year-over-year increase of 4.13%. This contributed to the annual value of $124.0 million for FY2024, which is 14.51% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Inventory Average of $124.0 million as of FY2024, which was up 14.51% from $108.3 million recorded in FY2023.
  • Ani Pharmaceuticals' Inventory Average's 5-year high stood at $124.0 million during FY2024, with a 5-year trough of $60.5 million in FY2020.
  • For the 3-year period, Ani Pharmaceuticals' Inventory Average averaged around $109.9 million, with its median value being $108.3 million (2023).
  • Data for Ani Pharmaceuticals' Inventory Average shows a peak YoY grew of 28.57% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Ani Pharmaceuticals' Inventory Average stood at $60.5 million in 2020, then grew by 28.57% to $77.7 million in 2021, then rose by 25.29% to $97.4 million in 2022, then rose by 11.17% to $108.3 million in 2023, then increased by 14.51% to $124.0 million in 2024.